Philip Hodges - 25 Sep 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
25 Sep 2025
Transactions value $
$0
Form type
4
Filing time
29 Sep 2025, 16:13:47
Previous filing
30 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hodges Philip Director C/O ALTIMMUNE, INC., 910 CLOPPER ROAD,, SUITE 201S, GAITHERSBURG /s/ Gregory Weaver, as Attorney-in-Fact 29 Sep 2025 0001705562

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +48.8K $0.00 48.8K 25 Sep 2025 Common Stock, par value $0.0001 48.8K $3.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney